Welcome
Support Centre
22 May 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Does aldosterone blockade improve endothelial dysfunction in patients with coronary artery disease but without heart failure?
ISRCTN ISRCTN70010120
ClinicalTrials.gov identifier
Public title Does aldosterone blockade improve endothelial dysfunction in patients with coronary artery disease but without heart failure?
Scientific title
Acronym N/A
Serial number at source Sha001
Study hypothesis Aldosterone blockade improves endothelial function in patients with coronary artery disease without heart failure
Lay summary
Ethics approval Approved by the Regional Research Ethics Committee on 09/07/2004, reference number: 04/S1401/82
Study design Randomised, double-blind, placebo-controlled crossover trial
Countries of recruitment United Kingdom
Disease/condition/study domain Coronary artery disease
Participants - inclusion criteria 1. Patient with known coronary artery disease
2. Chronic stable angina
Participants - exclusion criteria 1. Left ventricular systolic dysfunction
2. Renal failure
3. Hyperkalaemia
4. Warfarin therapy
Anticipated start date 05/01/2005
Anticipated end date 31/12/2006
Status of trial Completed
Patient information material
Target number of participants 88
Interventions Spironolactone versus placebo
Primary outcome measure(s) Improvement in endothelial function
Secondary outcome measure(s) 1. Changes in brain natriuretic peptide (BNP)
2. Amino-terminal propeptide of type III procollagen (PIIINP)
3. Angiotensin converting enzyme (ACE) activity
4. Heart rate variability
5. QT dispersion
Sources of funding British Hearth Foundation
Trial website
Publications
Contact name Dr  Nimit  Shah
  Address Department of Clinical Pharmacology
Level 7
Ninewells Hospital
  City/town Dundee
  Zip/Postcode DD1 9SY
  Country United Kingdom
Sponsor University of Dundee (UK)
  Address Department of Clinical Pharmacology
Level 7
Ninewells Hospital
  City/town Dundee
  Zip/Postcode DD1 9SY
  Country United Kingdom
Date applied 21/02/2006
Last edited 07/12/2010
Date ISRCTN assigned 29/03/2006
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central